by Damon Salvatore | Jul 5, 2021 | Free Press Releases
Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages Roots Analysis is pleased to announce the...
by Damon Salvatore | Jul 5, 2021 | Free Press Releases
To order this 375+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html Key Inclusions A detailed review of the ophthalmic drugs contract manufacturing market landscape, featuring a list of over 240...
by Damon Salvatore | Jul 5, 2021 | Free Press Releases
Owing to various reasons, such as growing manufacturing demand, need for specialized facilities, equipment and operational expertise, and high costs of development associated with certain drugs / therapies, a number of ophthalmic drug developers have demonstrated a...
by Damon Salvatore | Jul 5, 2021 | Free Press Releases
Over time, pharmaceutical players have demonstrated significant interest in this domain and have launched clinical research initiatives to investigate the relevance and applications of these novel biomarkers. Several companies have already developed / are developing...
by Damon Salvatore | Jul 5, 2021 | Free Press Releases
Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions Roots Analysis...